4.8 Review

The role of porphyrin chemistry in tumor imaging and photodynamic therapy

期刊

CHEMICAL SOCIETY REVIEWS
卷 40, 期 1, 页码 340-362

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/b915149b

关键词

-

资金

  1. NIH [CA 55791, CA 114053, CA-109914, CA 127369, CA 127369-02S1]
  2. Oishei Foundation
  3. Oncologic Foundation of Buffalo and Roswell Park Alliance Foundation
  4. The Mallinckrodt Medical Inc. St. Louis (USA)
  5. [CA-119358]
  6. NATIONAL CANCER INSTITUTE [R21CA114053, R33CA109914, R01CA119358, R01CA127369, R21CA109914, P30CA016056, P01CA055791] Funding Source: NIH RePORTER

向作者/读者索取更多资源

In recent years several review articles and books have been published on the use of porphyrin-based compounds in photodynamic therapy (PDT). This critical review is focused on (i) the basic concept of PDT, (ii) advantages of long-wavelength absorbing photosensitizers (PS), (iii) a brief discussion on recent advances in developing PDT agents, and (iv) the various synthetic strategies designed at the Roswell Park Cancer Institute, Buffalo, for developing highly effective long-wavelength PDT agents and their utility in constructing the conjugates with tumor-imaging and therapeutic potential (Theranostics). The clinical status of certain selected PDT agents is also summarized (205 references).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据